Stocksigma LogoStocksigma Logo

GSK Pharmaceuticals Reports Q2 Results and Key Leadership Appointments

GlaxoSmithKline Pharmaceuticals reported consolidated revenue of ₹1,183.57 crore for the quarter ended 30th Sep'26, up 20.8% YoY from ₹979.94 crore

GSK Pharmaceuticals Reports Q2 Results and Key Leadership Appointments

GlaxoSmithKline Pharmaceuticals Ltd · Financial Result · 04 Nov 2026, 12:27 am

GSK Pharmaceuticals Reports Q2 Results and Key Leadership Appointments GlaxoSmithKline Pharmaceuticals reported consolidated revenue of ₹1,183.57 crore for the quarter ended 30th Sep'26, up 20.8% YoY from ₹979.94 crore. Net profit grew 30.4% YoY to ₹335.88 crore, compared to ₹257.49 crore in the prior-year period, supported by ₹72.78 crore in other income (including ₹42.09 crore tax refund interest). Basic EPS stood at ₹19.83. The board approved the appointment of Sandeep Seth as Head - Ethics & Compliance and proposed Walker Chandiok & Co LLP as Statutory Auditors for five years starting FY28.

Original exchange filing (PDF)

More announcements from GlaxoSmithKline Pharmaceuticals Ltd

All GlaxoSmithKline Pharmaceuticals Ltd announcements